CJC-1295 No DAC (10mg)

Login to view prices.

Existing research has found the following:

  • Supports Sustained Growth Hormone Release Research – Studied for its potential to stimulate prolonged GH secretion through GHRH receptor activation.

  • Explores Muscle Growth & Recovery Mechanisms – Investigated for promoting lean tissue development and enhancing post-exertion recovery.

  • Evaluates Metabolic & Lipolytic Effects – Examined for improving fat metabolism and overall body composition in experimental studies.

30 DAY RETURN PERIOD

100% SECURE CHECKOUT

Description

Growth-Hormone Secretagogue Research

  • CJC-1295 (without DAC) is a short-acting GHRH analog studied in pre-clinical models for its ability to stimulate pituitary growth-hormone (GH) secretion through activation of the GHRH receptor, enabling research into pulsatile GH release and hypothalamic–pituitary signaling.

Muscle-Growth and Recovery Studies

  • In animal and cellular systems, CJC-1295 has been observed to increase IGF-1 expression and anabolic signaling, supporting its use in muscle-repair, recovery, and regeneration models.

Metabolic and Fat-Oxidation Models

  • Laboratory data suggest that GH-releasing peptides such as CJC-1295 enhance lipid metabolism and promote lipolysis via GH-mediated pathways, providing a framework for studying metabolic efficiency and fat-reduction mechanisms.

Sleep and Circadian-Endocrine Research

  • Pre-clinical findings indicate that GH-axis modulation by CJC-1295 may influence slow-wave sleep and circadian hormone patterns, making it useful for research into endocrine feedback and neuroendocrine regulation.

Tissue-Repair and Collagen-Synthesis Studies

  • CJC-1295 has been evaluated in in-vitro systems for its potential to promote fibroblast proliferation and collagen production, providing insight into wound-healing and extracellular-matrix remodeling processes.

Cellular-Regeneration and Longevity Research

  • Experimental literature links GH-releasing analogs to pathways involved in mitochondrial efficiency and cellular renewal, offering a tool for studying regenerative biology and age-related cellular decline.

Bone-Density and Joint-Health Models

  • GH-axis activation by CJC-1295 has been shown in animal research to stimulate osteoblastic activity and cartilage matrix formation, supporting skeletal and connective-tissue research.

Combination Studies with GHRPs

  • CJC-1295 is frequently co-studied with ghrelin-mimetic peptides such as GHRP-2, GHRP-6, and Ipamorelin to assess synergistic GH-release kinetics and dual-pathway endocrine activation.

STORAGE DETAILS

Lyophilized CJC-1295 NO DAC peptide is stable at room temperature for 90 days; however, it should NOT be stored below freezing for any extended period of time. After reconstituting, CJC-1295 NO DAC should be refrigerated at temperatures not to exceed 36°F.

Product Specifications

  • Appearance: Solid, white powder in 3mL glass ampule

  • Chemical Formula: C152H252N44O42

  • PubChem CID: (Specify if available)

  • CAS Number: 863288-34-0

  • Molecular Weight: 3367.96 g/mol

  • Synonyms: CJC-1295 Without DAC, CJC-1295 No DAC, GRF (1-29) analog

  • Storage: Store at ≤6°C, sealed, away from heat, light, and moisture.

  • Concentration: ≥98%

    Research Use Only (RUO). Not for human or animal use. Not for diagnostic, therapeutic, or clinical applications. No claims are made regarding GH release, fat metabolism, or tissue repair in humans. End-user assumes responsibility for determining suitability for specific research protocols.

You may also like